keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Main Conference Day 1 (28th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Main Conference Day 1 (28th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
Showing 1 of 1 Streams
Breaks & Networking
08:00 - 08:55
Registration & Coffee
Showing 5 of 5 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Downstream Processing
ATMP Development & Manufacturing
Digital Biomanufacturing & Data-Driven Operations
08:55 - 09:00
Chairperson's Opening Remarks
09:00 - 09:30
Beyond Random: Targeted Integration vs. Transposon Systems for High-Titre Stability
- Lasse Ebdrup Pedersen - Associate Professor, The Technical University of Denmark
09:30 - 10:00
CRISPR in Action: Multi-Gene Editing for Next-Generation Host Cells
08:55 - 09:00
Chairperson's Opening Remarks
09:00 - 09:30
The Digital Handshake: De-Risking Your Upstream CDMO Tech Transfer
09:30 - 10:00
Outsourcing CMC Development and Bio-Manufacturing to External Partners as a Strategic Bioprocessing Approach
- Ulrich Ruemenapp - Head of Launch Preparation, Bayer AG
08:55 - 09:00
Chairperson's Opening Remarks
09:00 - 09:30
Towards Platform Processes in Downstream Processing of Viral Gene Therapy Vectors
- Alois Jungbauer - Professor, Dept. of Biotechnology, University of Natural Resources and Applied Life Sciences
09:30 - 10:00
CASE STUDY: Tackling Instability in ADC purification - Minimising Aggregation and Free Drug Payload
08:55 - 09:00
Chairperson's Opening Remarks
- Felix Wittkopp - Director of Purification Development Gene Therapy - Gene Therapy Technical Research & Development, Roche, Germany
09:00 - 09:30
Fuelling the Future for Manufacturing recombinant AAV
- Frank Agbogbo - Vice President, Forge Biologics, USA
09:30 - 10:00
Ditching the Plasmid Dependency: Engineering a Resilient and Cost-Effective Raw Material Strategy for ATMP Pipelines
08:55 - 09:00
Chairperson's Opening Remarks
- Thibaut Angevin - Director CMC Proteins, BioNTech SE
09:00 - 09:30
AI for Pharma/Biotech: Moral Compass Within
- Kat Kozyrytska - Founder, Cell Therapy Manufacturability Program
09:30 - 10:00
A Practical Roadmap for Harmonising Data to Optimise your Processes
- Francisca Gouveia - Innovation Data & Digital Lead, Novartis, France
Showing 1 of 1 Streams
Breaks & Networking
10:30 - 11:15
Morning Break
Showing 5 of 5 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Downstream Processing
ATMP Development & Manufacturing
Digital Biomanufacturing & Data-Driven Operations
11:15 - 11:45
Implementing Raman: From Real-Time Monitoring to Automated Control
11:45 - 12:15
CASE STUDY: From Months to Weeks - Slashing Timelines with an In Silico Upstream Digital Twin
- Alireza Ehsani - Senior Data Scientist - Upstream Process Development, Boehringer Ingelheim
12:15 - 12:45
Sponsored Session: The AI-Powered Lab: Integrated Platforms for Smart Data & Analysis
11:15 - 11:45
Building for the Future: Phase-Appropriate CMC Strategies
- A Representative from Resolution Therapeutics - (Pending Final Confirmation), Resolution Therapeutics
11:45 - 12:15
CASE STUDY: Bridging the Valley of Death - De-Risking ATMP Tech Transfer from Lab to GMP
- Pablo Mancheño Corvo - Associate Scientific Director, Takeda, Spain
11:15 - 11:45
Applying AI to Predict and Control Critical Quality Attributes in Upstream Processing
11:45 - 12:15
Predictive Purification: Leveraging AI/ML to Boost Downstream Yield and Purity
12:15 - 12:45
Sponsored Session: Accelerating Process Development: Leveraging AI and ML to Optimize your Process Parameters
Showing 1 of 1 Streams
Breaks & Networking
12:45 - 14:30
Grand Opening of Exhibit Hall & Networking Luncheon
14:30 - 14:45
Transition to Plenary Session
Showing 1 of 1 Streams
Keynote Plenary
14:45 - 14:50
Chairperson's Opening Remarks
14:50 - 15:50
INTERACTIVE ROUNDTABLE SESSION - Breaking Down the Silos: A Cross-Functional Attack on Biopharma's Grand Challenges
Join this dynamic, peer-led session to tackle biopharma's biggest challenges. Choose a table and engage in an open discussion to share insights and find collaborative solutions.
Choose Your Topic:
- The USP-DSP Handshake: Debate how to create a truly integrated process to solve downstream bottlenecks caused by upstream intensification.
- Validating AI in a GMP World: Tackle the practical steps and regulatory risks for validating AI/ML in a GMP environment.
- Is The 'Platform' Dead for Downstream?: Discuss the future of purification beyond the traditional mAb platform for novel modalities like bispecifics and ADCs.
- Learning from History: What ATMPs can Learn from mAbs: When will cell and gene therapies have their "CHO moment"? Explore key lessons to accelerate ATMP industrialization.
- The ATMP COGS Crisis: Brainstorm radical solutions to drive down the commercially unsustainable manufacturing costs for cell and gene therapies.
- The Sustainability Mandate: Discuss the practical implementation of sustainability as it moves from a "nice-to-have" to a regulatory and business imperative.
- Emerging Markets & Global Supply: Discuss the challenges and opportunities of building biomanufacturing capacity and supply chains in emerging markets.
15:50 - 16:25KEYNOTE
Keynote Address from European Commission
- Thomas Van Cangh - Deputy Head of Unit - DG SANTE, European Commission
16:25 - 17:00
Keynote Presentation 2
17:00 - 19:00
Networking Reception in the Exhibition Hall
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
